BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Han Y, Zhi WH, Xu F, Zhang CB, Huang XQ, Luo JF. Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials. World J Gastroenterol 2021; 27(19): 2415-2433 [PMID: 34040331 DOI: 10.3748/wjg.v27.i19.2415]
URL: https://www.wjgnet.com/1948-5182/full/v27/i19/2415.htm
Number Citing Articles
1
Yi Liu, Juan Xiang, Gang Peng, Chenfu Shen. Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer CohortFrontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.785370
2
Zhiguo Wang, Baofeng Yang. Polypharmacology2022; : 73 doi: 10.1007/978-3-031-04998-9_3
3
Bin Xu, Hui-Chuan Sun. Camrelizumab: an investigational agent for hepatocellular carcinomaExpert Opinion on Investigational Drugs 2022; 31(4): 337 doi: 10.1080/13543784.2022.2022121
4
Jinfeng Bai, Ming Huang, Bohan Song, Wei Luo, Rong Ding. The Current Status and Future Prospects for Conversion Therapy in the Treatment of Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2023; 22: 153303382311597 doi: 10.1177/15330338231159718
5
Jingxin Yan, Manjun Deng, Ting Li, Changhao Dong, Minglan Wang, Shunyu Kong, Yingxing Guo, Haining Fan. Efficacy and complications of transarterial chemoembolization alone or in combination with different protocols for hepatocellular carcinoma: A Bayesian network meta-analysis of randomized controlled trialsiLIVER 2023; 2(2): 130 doi: 10.1016/j.iliver.2023.03.002
6
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalitiesWorld Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
7
Ping Li, Ming Hu, Mei Liu, Xiangyu Ren, Donghong Liu, Jiluo Liu, Jianhua Yin, Xiaojie Tan, Guangwen Cao. The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysisFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1197782
8
Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, Lorenza Rimassa, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Francesco Tovoli, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Tiziana Pressiani, Takumi Kawaguchi, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Fabio Piscaglia, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Massimo Iavarone, Giovanni Di Costanzo, Fabio Marra, Mario Scartozzi, Emiliano Tamburini, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Antonella Cammarota, Valentina Burgio, Stefano Cascinu, Andrea Casadei-Gardini. Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world studyJournal of Cancer Research and Clinical Oncology 2023; 149(9): 5591 doi: 10.1007/s00432-022-04512-1
9
Zebing Song, Xiaodong Song, Hang Li, Zongbing Cheng, Zengyi Mo, Xuewei Yang. Identification and validation of a prognostic-related mutant gene DNAH5 for hepatocellular carcinomaFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1236995
10
Ignacio Ventura, Lorena Sanchiz, María Ester Legidos-García, María Teresa Murillo-Llorente, Marcelino Pérez-Bermejo. Atezolizumab and Bevacizumab Combination Therapy in the Treatment of Advanced Hepatocellular CancerCancers 2023; 16(1): 197 doi: 10.3390/cancers16010197
11
Maria Cerreto, Ferdinando Cardone, Lucia Cerrito, Leonardo Stella, Francesco Santopaolo, Maria Pallozzi, Antonio Gasbarrini, Francesca Romana Ponziani. The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal SequenceCurrent Oncology 2023; 30(10): 8774 doi: 10.3390/curroncol30100633
12
Osama Altayar, Raj Shah, Charissa Y. Chang, Yngve Falck-Ytter, Andrew J. Muir. AGA Technical Review on Systemic Therapies for Hepatocellular CarcinomaGastroenterology 2022; 162(3): 937 doi: 10.1053/j.gastro.2021.12.275
13
Hui-Chuan Sun, Xiao-Dong Zhu. Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An OverviewFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.772195
14
Yunyan Ling, Meng Jin, Meiyan Zhu, Yan Wang, Yong Chen, Zhenwei Peng. Efficacy of Different Treatments for Patients with Advanced Hepatocellular Carcinoma: A System Review and Network Meta-AnalysisInternational Journal of Surgery Oncology 2022; 7(1): 58 doi: 10.29337/ijsonco.140